This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bogdan, J. A.
Right arrow Articles by Blake, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bogdan, J. A.
Right arrow Articles by Blake, M. S.
Agricola
Right arrow Articles by Bogdan, J. A.
Right arrow Articles by Blake, M. S.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, October 2003, p. 6272-6279, Vol. 69, No. 10
0099-2240/03/$08.00+0     DOI: 10.1128/AEM.69.10.6272-6279.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Identification of Peptides That Mimic the Pertussis Toxin Binding Site on Bovine Fetuin

John A. Bogdan,1* Wei Yuan,1 Karen O. Long-Rowe,1 Jawad Sarwar,1 Eric Allen Brucker,2 and M. S. Blake1

Baxter Healthcare Corporation, Columbia, Maryland 21046,1 Baxter Healthcare Corporation, Boulder, Colorado 803012

Received 16 December 2002/ Accepted 3 July 2003

The introduction of acellular pertussis vaccines has greatly enhanced the safety profile of vaccines to prevent whooping cough. Pertussis toxin (Ptx) is one component produced by Bordetella pertussis that is contained in all of these vaccines, either in combination with other known pertussis virulence factors or as the sole pertussis component, combined with tetanus and diphtheria toxoids. A hydrogen peroxide toxoid of Ptx has been shown to be efficacious in preventing pertussis infections in a mass vaccination trial and is presently licensed in the United States and Europe (B. Trollfors, J. Taranger, T. Lagergard, L. Lind, V. Sundh, G. Zackrisson, C. U. Lowe, W. Blackwelder, and J. B. Robbins, N. Engl. J. Med. 333:1045-1050, 1995). The industrial production of Ptx can be performed through the cultivation of B. pertussis in well-defined growth media, in which the components can be well characterized and their origins can be documented. Once the bacteria are removed from the culture, Ptx can be isolated from the supernatant and purified by using the technique described by Sekura et al. (R. D. Sekura, F. Fish, C. R. Manclark, B. Meade, and Y. L. Zhang, J. Biol. Chem. 258:14647-14651, 1983). The only drawback of this procedure, which combines two affinity chromatography steps, one with Blue Sepharose and a second with matrix-bound bovine fetuin (BF), is the source and purity of the BF. Concern about vaccine preparations that may possibly risk contamination by material associated with bovine spongioform encephalopathy has continued to increase. We thus sought a replacement for the BF affinity chromatography and, more specifically, for the glycosidic moiety on BF. We describe here the identification of a seven-amino-acid peptide that mimics the glycosidic moiety on BF to which Ptx binds. Furthermore, we have constructed an affinity column containing this peptide that can be used to replace BF in Ptx purification. Finally, we used the X-ray crystallographic structure of Ptx bound to the oligosaccharide moiety of BF as a scaffold and replaced the oligosaccharide with the peptide.


* Corresponding author. Present address: National Institute of Allergy and Infectious Diseases, 6700-B Rockledge Dr., MSC 7616, Bethesda, MD 20892-7616. Phone: (301) 402-7372. Fax: (301) 402-2638. E-mail: jbogdan{at}niaid.nih.gov.


Applied and Environmental Microbiology, October 2003, p. 6272-6279, Vol. 69, No. 10
0099-2240/03/$08.00+0     DOI: 10.1128/AEM.69.10.6272-6279.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.